RG
IPXL

Redmile Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Redmile Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-961,100
Closed -$19.2M – 65
2013
Q2 		$19.2M Buy
+961,100
New +$17.1M 3.38% 10

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Redmile Group's IPXL Position: Q3 2013 in Review

Redmile Group sold out of Impax Laboratories, Inc. (IPXL) in Q3 2013, closing a stake of 961,100 shares — an estimated $19.2M sold.

Redmile Group first reported a position in IPXL in Q2 2013 and held it in 1 quarter. The position peaked at $19.2M in Q2 2013. 158 funds tracked by Wall St. Rank hold IPXL as of Q3 2013.

  • Redmile Group reported no remaining Impax Laboratories, Inc. position as of Q3 2013 after selling out during the quarter.
  • Redmile Group sold 961,100 Impax Laboratories, Inc. shares in Q3 2013, an estimated $19.2M.
  • Redmile Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 1 quarter.
  • Redmile Group's Impax Laboratories, Inc. position peaked at $19.2M in Q2 2013.
  • 158 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2013.

Based on Redmile Group's 13F filing for Q3 2013, filed 14 Nov 2013.